Search

Author/Creator Winthrop, K

1. FRI0496 Comparing tofacitinib safety profile in patients with psoriatic arthritis in clinical studies with real-world data. (15th June 2017)

Authors:
Curtis, JR; Yun, H; FitzGerald, O; Winthrop, K; Azevedo, VF; Burmester, G; Rigby, WFC; Kanik, KS; Rojo, R; Menon, S; Wang, C; Biswas, P; Hendrikx, T; Palmetto, N
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
676
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. THU0173 Long term safety and efficacy of filgotinib in a phase 2B open label extension study in patients with rheumatoid arthritis: results up to 144 weeks. (15th June 2017)

Authors:
Alten, R; Westhovens, R; Kavanaugh, A; Genovese, M; Winthrop, K; Greenwald, M; Ponce, L; Enriquez, F; Stanislavchuk, M; Mazur, M; Spindler, A; Cseuz, R; Nikulenkova, N; Glowacka-Kulesz, M; Szombati, I; Dudek, A; Meuleners, L; Tasset, C; Harrison, P; Aa, A Van der
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008. (20th November 2008)

Authors:
Furst, D E; Keystone, E C; Kirkham, B; Fleischmann, R; Mease, P; Breedveld, F C; Smolen, J S; Kalden, J R; Burmester, G R; Braun, J; Emery, P; Winthrop, K; Bresnihan, B; De Benedetti, F; Dörner, T; Gibofsky, A; Schiff, M H; Sieper, J; Singer, N; Van Riel, P L C M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 67(2008)Supplement 3
Page Start:
iii2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. (7th December 2009)

Authors:
Furst, D E; Keystone, E C; Fleischmann, R; Mease, P; Breedveld, F C; Smolen, J S; Kalden, J R; Braun, J; Bresnihan, B; Burmester, G R; De Benedetti, F; Dörner, T; Emery, P; Gibofsky, A; Kavanaugh, A; Kirkham, B; Schiff, M H; Sieper, J; Singer, N; Van Riel, P L C M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 69(2010)Supplement 1
Page Start:
i2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010. (21st February 2011)

Authors:
Furst, D E; Keystone, E C; Braun, J; Breedveld, F C; Burmester, G R; De Benedetti, F; Dörner, T; Emery, P; Fleischmann, R; Gibofsky, A; Kalden, J R; Kavanaugh, A; Kirkham, B; Mease, P; Sieper, J; Singer, N G; Smolen, J S; Van Riel, P L C M; Weisman, M H; Winthrop, K
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70(2011)Supplement 1
Page Start:
i2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. (28th March 2012)

Authors:
Furst, D E; Keystone, E C; Braun, J; Breedveld, F C; Burmester, G R; De Benedetti, F; Dörner, T; Emery, P; Fleischmann, R; Gibofsky, A; Kalden, J R; Kavanaugh, A; Kirkham, B; Mease, P; Sieper, J; Singer, N G; Smolen, J S; Van Riel, P L C M; Weisman, M H; Winthrop, K
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 2
Page Start:
i2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗